These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism. Wilcken DE; Sim AS; Wang J; Wang XL Mol Genet Metab; 2007 Aug; 91(4):309-17; discussion 308. PubMed ID: 17560156 [TBL] [Abstract][Full Text] [Related]
31. Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy. Nemeth Z; Cziraki A; Szabados S; Biri B; Keki S; Koller A PLoS One; 2015; 10(8):e0135498. PubMed ID: 26313940 [TBL] [Abstract][Full Text] [Related]
32. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698 [TBL] [Abstract][Full Text] [Related]
33. The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia. Demir B; Demir S; Pasa S; Guven S; Atamer Y; Atamer A; Kocyigit Y J Obstet Gynaecol; 2012 Aug; 32(6):525-8. PubMed ID: 22779953 [TBL] [Abstract][Full Text] [Related]
34. Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials. Szuba A; Podgórski M Pharmacol Rep; 2006; 58 Suppl():16-20. PubMed ID: 17332667 [TBL] [Abstract][Full Text] [Related]
35. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. Selley ML J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage. Notsu Y; Nabika T; Bokura H; Suyama Y; Kobayashi S; Yamaguchi S; Masuda J Am J Hypertens; 2009 Mar; 22(3):257-62. PubMed ID: 19057516 [TBL] [Abstract][Full Text] [Related]
37. Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition. Zsuga J; Gesztelyi R; Török J; Kéki S; Bereczki D Med Hypotheses; 2005; 65(6):1091-8. PubMed ID: 16125868 [TBL] [Abstract][Full Text] [Related]
38. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Böger RH; Bode-Böger SM Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410 [TBL] [Abstract][Full Text] [Related]
39. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow. Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608 [TBL] [Abstract][Full Text] [Related]
40. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Mao D; Che J; Li K; Han S; Yue Q; Zhu L; Zhang W; Li L Arch Gynecol Obstet; 2010 Oct; 282(4):371-5. PubMed ID: 19806356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]